Related Experiment Video
Updated: May 20, 2025

Reverse Total Shoulder Arthroplasty
Published on: July 5, 2011
Botulinum toxin for posterior shoulder instability unresponsive to conventional management
Enrico Sebastiani1, Nicolò Giuseppe Biavardi2, Andrea Massimiani3
1Ortopedia e Traumatologia, Ospedale degli Infermi, Narni, Piemonte, Italy.
Botulinum toxin A injections successfully treated shoulder pain and instability from a posterior labral tear. This novel approach offers a new option for persistent musculoskeletal pain caused by muscle hypertonicity.
Area of Science:
- Orthopedics
- Neurology
- Musculoskeletal Disorders
Background:
- Persistent shoulder pain and instability can significantly impact quality of life.
- Recurrent symptoms after surgical repair may indicate underlying muscular imbalances.
- Hypertonicity of specific muscles, like the latissimus dorsi, can contribute to shoulder dysfunction.
Purpose of the Study:
- To evaluate the efficacy of botulinum toxin A injections in treating refractory shoulder pain and instability.
- To explore a novel application of botulinum toxin beyond its traditional use in spasticity management.
- To address pain and dysfunction stemming from muscular hypertonicity in the shoulder.
Main Methods:
- A case report detailing the treatment of a middle-aged male patient with posterior labral tear and capsular laxity.
- Diagnostic assessment identified latissimus dorsi hypertonicity as a cause of persistent pain post-arthroscopic repair.
- Therapeutic intervention involved targeted botulinum toxin A injections into the latissimus pars ascendens.
Main Results:
- Significant reduction in shoulder pain and improvement in functional status were observed within one month post-injection.
- The patient experienced complete pain relief and resumed normal activities at six months.
- The treatment effectively addressed the muscular imbalance contributing to shoulder instability.
Conclusions:
- Botulinum toxin A injections represent a promising, innovative therapeutic option for refractory shoulder pain and dysfunction.
- This case highlights the potential for expanding the indications of botulinum toxin in managing musculoskeletal disorders characterized by muscle hypertonicity.
- Further research is warranted to establish the broader efficacy and safety profile of this treatment modality.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Pharmocokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...

